DENVER, COLO. — MARCH 13, 2024 — American Cancer Society Cancer Action Network (ACS CAN) volunteers from across Colorado convened at the State Capitol on Wednesday. They urged lawmakers to pass SB 124, which if enacted would ensure biomarker testing is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.
The following was originally published in the Empire Report on March 13, 2024.
The House Energy and Commerce Committee’s Subcommittee on Health today marked up the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, H.R. 3916. The bipartisan legislation would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028.
West Virginia Can and Must Do Better to Boost Funding to Combat Tobacco Use, Protect Public Health
The American Cancer Society Cancer Action Network is Encouraged as Flawed Biomarker Legislation Does Not Pass
The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.
The Florida legislature ended its 2024 session today by passing a budget that included landmark funding for cancer priorities in the Sunshine State, including meaningful increases for the Florida Cancer Innovation Fund, the Mary Brogan Breast and Cervical Cancer Early Detection Program and the Casey DeSantis Cancer Research Program.
NEW YORK, NY – March 8, 2024– Ear
The Biden Cancer Moonshot announced today the expansion of coverage for patient navigation services in plans from seven health insurance companies.
WASHINGTON, D.C.— March 7, 2024 —Ahead of President Biden’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is calling on the president to emphasize the need for continued bipartisan support for increased federal investment for cancer research at the National Institutes of Health (NIH) and National Cancer Institute (NCI) as well as prevention program funding at the Centers for Disease Control and Prevention (CDC). Additionally, ACS CAN is urging the president to finalize the Food and Drug Administration’s rule prohibiting the sale of menthol in cigarettes without delay.